newsfilter
← Latest News
GlobeNewswire·

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

CAMBRIDGE, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA